Meijie Chen, Peter J. Little, Sudong Kong, Maciej Banach, Jianping Weng, Suowen Xu. Aclysiran, an RNAi therapeutic agent targeting ACLY, treats hypercholesterolemia and atherosclerosis in ApoE-/- miceJ. Acta Pharmaceutica Sinica B, 2024, 14(12): 5505-5508. DOI: 10.1016/j.apsb.2024.10.008
Citation: Meijie Chen, Peter J. Little, Sudong Kong, Maciej Banach, Jianping Weng, Suowen Xu. Aclysiran, an RNAi therapeutic agent targeting ACLY, treats hypercholesterolemia and atherosclerosis in ApoE-/- miceJ. Acta Pharmaceutica Sinica B, 2024, 14(12): 5505-5508. DOI: 10.1016/j.apsb.2024.10.008
shu

Aclysiran, an RNAi therapeutic agent targeting ACLY, treats hypercholesterolemia and atherosclerosis in ApoE-/- mice

    Abstract
    • FullText(HTML)
  • loading
    • References (8)
    • Relative Articles
  • Supplements (0)

Catalog

    Copyright © 2014 Editorial Office of Acta Pharmaceutica Sinica

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return